Botana M, Escalada J, Merchante , Reyes R, Rozas P (2022) Prevention of cardiorenal complications with sodiumglucose cotransporter type 2 inhibitors: a narrative review
2021 Oct;9(10):653-662 Author: Dr Maeve Durkan, Consultant in Diabetes, Endocrinology, and Metabolism, Bon Secours Hospital, Cork, and the Cork Clinic, and Senior Clinical Lecturer in Medicine at University College Cork You must be logged in to post a comment
Theyll also identify potential issues and interactions before they cause serious problems
NCT04881760) examining its effects on body weight and glycaemic parameters data from which have been published in peer-reviewed literature, providing a framework for ongoing basic science and mechanistic research into triple incretin receptor pharmacology
Semaglutide was working